GENEVA, March 9 -- ASSEMBLY BIOSCIENCES, INC. (Two Tower Place, 7th FloorSouth San Francisco, California 94080) filed a patent application (PCT/IB2024/058310) for "A CRYSTALLINE FORM OF 2-(3-(2,,5'-DIFLUORO-[1,1'-BIPHENYL]-4-YL)-2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)-4-METHYLTHIAZOLE-5-SULFONAMIDE" on Aug 27, 2024. With publication no. WO/2025/046457, the details related to the patent application was published on Mar 06, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ZONG, Zhixin (c/o Assembly Biosciences, Inc.Two Tower Place, 7th FloorSouth San Francisco, California 94080), WU, Yi (c/o Assembl...